Sung-Ho Jeon

Title: Innovations of Sung-Ho Jeon in Influenza Virus Research

Introduction

Sung-Ho Jeon is a prominent inventor based in Suwon-si, South Korea. He has made significant contributions to the field of virology, particularly in the study and treatment of influenza virus infections. With a total of 3 patents to his name, Jeon's work is pivotal in advancing medical research and therapeutic strategies.

Latest Patents

Jeon's latest patents focus on nucleic acid molecules, polypeptides, antibodies, and compositions for treating and detecting influenza virus infection. His innovations include polynucleotides and polypeptides that play a crucial role in the infection process of influenza virus in cells. These patents also describe nucleic acid molecules that contain a polynucleotide sequence capable of specifically binding to the polypeptides he has developed. Furthermore, he provides methods for using these nucleic acid molecules, polynucleotides, and antibodies for diagnosing, treating, and preventing influenza virus infections.

Career Highlights

Sung-Ho Jeon is associated with Yeda Research and Development Co. Ltd., where he continues to push the boundaries of research in his field. His work has not only contributed to scientific knowledge but also has practical implications for public health.

Collaborations

Jeon has collaborated with notable scientists such as Ruth Arnon and Basak Kayhan, enhancing the impact of his research through shared expertise and innovative ideas.

Conclusion

Sung-Ho Jeon's contributions to influenza virus research exemplify the importance of innovation in the medical field. His patents and ongoing work are vital for developing effective treatments and diagnostic methods for influenza virus infections.